RenovoRx, Inc.
RNXT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001574094
No open-market purchases or sales by RenovoRx, Inc. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $9.00M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in RenovoRx, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- +5 vs. Q3 2024
- Shares held
- 1.01M
- −876.7K (−46.4%) vs. Q3 2024
- Total value
- $1.31M
- −$695.2K (−34.7%) vs. Q3 2024
- New holders
- 6
- 3 more added
- Sold out
- 1
- 3 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RNXT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 28 | $9.00M |
| Q1 2026 | 31 | $8.58M |
| Q4 2025 | 33 | $6.83M |
| Q3 2025 | 31 | $9.04M |
| Q2 2025 | 25 | $11.6M |
| Q1 2025 | 27 | $9.98M |
| Q4 2024 | 18 | $1.31M |
| Q3 2024 | 13 | $2.00M |
| Q2 2024 | 17 | $1.01M |
| Q1 2024 | 10 | $441.6K |
| Q4 2023 | 12 | $758.1K |
| Q3 2023 | 14 | $473.5K |
| Q2 2023 | 9 | $552.2K |
| Q1 2023 | 12 | $9.64M |
| Q4 2022 | 11 | $2.75M |
| Q3 2022 | 13 | $2.49M |
| Q2 2022 | 11 | $2.35M |
| Q1 2022 | 12 | $482.0K |
| Q4 2021 | 9 | $506.0K |
| Q3 2021 | 8 | $1.02M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding RenovoRx, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 40 | $52 | 0.00% | +40 | New |
| Bank of America Corp | 196 | $253 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 384 | $495 | 0.00% | +384 | New |
| Tower Research Capital LLC (TRC) | 817 | $1.05K | 0.00% | −3,253−79.9% | Reduced |
| Two Sigma Securities, LLC | 11,704 | $15.1K | 0.00% | +11,704 | New |
| UBS Group AG | 12,266 | $15.8K | 0.00% | +10,030+448.6% | Added |
| XTX Topco Ltd | 12,640 | $16.3K | 0.00% | +12,640 | New |
| Affinity Capital Advisors, LLC | 13,279 | $18.2K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 26,152 | $33.7K | 0.00% | 00.0% | Unchanged |
| Kestra Advisory Services, LLC | 35,520 | $45.8K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 37,757 | $48.7K | 0.00% | +37,757 | New |
| Charles Schwab Investment Management Inc | 49,232 | $63.5K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 64,900 | $83.7K | 0.00% | +64,900 | New |
| Millennium Management LLC | 76,814 | $99.1K | 0.00% | −5,539−6.7% | Reduced |
| Nixon Peabody Trust Co | 97,165 | $125.3K | 0.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 141,487 | $182.5K | 0.00% | +84,750+149.4% | Added |
| ADAR1 Capital Management, LLC | 197,250 | $254.5K | 0.05% | −117,942−37.4% | Reduced |
| Geode Capital Management, LLC | 235,748 | $304.1K | 0.00% | +2,811+1.2% | Added |
| Bank of Montreal | 0 | $0 | 0.00% | −975,000−100.0% | Sold out |